Evans, TR; Lofts, FJ; Mansi, JL; Glees, JP; Dalgleish, AG; Knight, MJ (1996) A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. BRITISH JOURNAL OF CANCER, 73 (10). 1260 - 1264 (5). ISSN 0007-0920 https://doi.org/10.1038/bjc.1996.241
SGUL Authors: Dalgleish, Angus George

Preview

["document_typename_application/pdf; charset=binary" not defined] Published Version Download (1MB) | Preview

Item Type:	Article
Additional Information:	PubMed ID: 8630289
Keywords:	Adenocarcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Epirubicin, Female, Fluorouracil, Humans, Infusions, Intravenous, Male, Middle Aged, Pancreatic Neoplasms, Science & Technology, Life Sciences & Biomedicine, Oncology, epirubicin, cisplatin, 5-fluorouracil, ATLANTIC ONCOLOGY PROGRAM, CHEMOTHERAPY, CARCINOMA, ADENOCARCINOMA, CATHETERS, TRIAL, epirubicin, cisplatin, 5-fluorouracil
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	BRITISH JOURNAL OF CANCER
ISSN:	0007-0920
Related URLs:	Author
Dates:	Date Event 1 May 1996 Published
Web of Science ID:	WOS:A1996UK32300018
	Download EPMC Full text (PDF)
	Download EPMC Full text (HTML)
URI:	https://openaccess.sgul.ac.uk/id/eprint/1485
Publisher's version:	https://doi.org/10.1038/bjc.1996.241

Actions (login required)

Edit Item